Adicet Bio

ACETNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$74.705 M

$7.98 +0.63%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$116.8M

Loss-making

Shares outstanding

9,361,490

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#320Telomir PharmaceuticalsTELO$79.8M
#321Gain TherapeuticsGANX$77.6M
#322Adicet BioACET$74.7M
#323TalpheraTLPH$74.2M
#324Acrivon TherapeuticsACRV$74.0M

Where these numbers come from

Share counts and financials for Adicet Bio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.